• Price (DKK)391.60
  • Today's Change1.65 / 0.42%
  • Shares traded177.86k
  • 1 Year change29.45%
  • Beta0.9506
Data delayed at least 20 minutes, as of Oct 23 2020 17:30 BST.
More ▼
Take Action
Take Action
Add this security to watchlist, portfolio, or create an alert to track market movement

    Key statistics

    On Friday, Novozymes A/S (0Q4U:LSE) closed at 391.60, -6.26% below its 52-week high of 417.76, set on Sep 16, 2020.
    52-week range
    256.29Mar 16 2020417.76Sep 16 2020
    Markit short selling activity
    Previous close389.95
    Average volume76.17k
    Shares outstanding231.26m
    Free float158.16m
    P/E (TTM)35.79
    Market cap90.54bn DKK
    EPS (TTM)10.94
    Annual div (ADY)5.25
    Annual div yield (ADY)1.34%
    Div ex-dateFeb 27 2020
    Div pay-dateMar 02 2020
    Data delayed at least 20 minutes, as of Oct 23 2020 17:30 BST.
    More ▼
    The Financial and Risk business of Thomson Reuters is now Refinitiv
    All markets data located on FT.com is subject to the FT Terms & Conditions
    All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
    Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.
    Markit Short Selling Activity © Markit. All rights reserved.
    Although Markit has made every effort to ensure this data is correct, nevertheless no guarantee is given to the accuracy or completeness. Any opinions or estimates expressed herein are those of Markit on the date of preparation and are subject to change without notice; however no such opinions or estimates constitute legal, investment or other advice. You must therefore seek independent legal, investment or other appropriate advice from a suitably qualified and/or authorised and regulated advisor prior to making any legal, investment or other decision. This is intended for information purposes only and is not intended as an offer or recommendation to buy, sell or otherwise deal in securities.